ShowMe Portal

Click here to learn more about the ShowMe Portal. Use your university ID to login or request access.


 


Loading video...


Biomedical Innovators Group

Connecting Clinical Ideas to Entrepreneurial and Technology Resources


Biomedical Innovators Group
Networking Event


“Current Trends in Personalized Diagnostics/Medicine”

4 to 6 p.m. Monday, Oct. 13, 2014
Acuff Auditorium
MU School of Medicine


Presentation and discussion from 4 to 5 p.m.
Reception from 5 to 6 p.m.

Guest Speaker:
Bob Basore
Vice President
Mallinckrodt Pharmaceuticals

Organized by the MU Institute for Clinical and Translational Science, MU Biodesign and Innovation Program, MU Coulter Translational Partnership Program, MU Office of Technology Management and Industry Relations, and The Mizzou Advantage.

The University of Missouri Biomedical Innovators Group (BIG) connects clinical needs to entrepreneurial and technology resources. BIG creates a novel networking opportunity for clinicians and other innovators to meet, share ideas and collaborate. One way BIG accomplishes its goals is by hosting bimonthly networking events. BIG also provides a process for submitting clinical ideas or technical innovations, early stage vetting, connections to a network of experts, consultation support and matchmaking for projects.

BIG is sponsored by the MU Institute for Clinical and Translational Science, MU Biodesign and Innovation Program, MU Coulter Translational Partnership Program, MU Office of Technology Management and Industry Relations, and Mizzou Advantage. The sponsors and other programs associated with the university are available to help translate discoveries into products and services for patients and the public.

Institute for Clinical and Translational Science

The University of Missouri Institute for Clinical and Translational Science (ICATS) transforms discoveries made in laboratories across MU into community-based products, services and practices for the state and nation. The institute is the focal point of MU's efforts to develop clinical and translational science programs that improve health through better research, education and public service.
Click here to learn more

Clinical Research Center

Part of the Institute for Clinical and Translational Science, MU's Clinical Research Center brings scientific discovery to the realm of patient care by supporting patients, volunteers and researchers who participate in clinical trials and other forms of clinical and translational research. Located on the fifth floor of MU's University Hospital and School of Medicine, the center is ideally positioned to serve as a bridge between clinical medicine and biomedical science. The center contains an advanced inpatient Phase 1 clinical trials unit, five inpatient beds, three outpatient exam rooms, a metabolic kitchen to support nutrition studies, an exercise facility, and many other resources to support investigators.
Click here to learn more

Coulter Translational Partnership Program

The Coulter Translational Partnership Program at MU is designed to increase the capacity and pace of biomedical innovation that ultimately benefits patients and society by addressing unmet clinical needs. Both "seed" and "bridge" funding awarded by the program focus on bringing engineering solutions to medical problems in order to create follow-on funding opportunities that can advance the translational process. The Coulter program supports protection of intellectual property, exploration of market opportunities, identification of potential partners, and financing for product development.
Click here to learn more

Office of Technology Management and Industry Relations

The MU Office of Technology Management and Industry Relations (OTMIR) works to identify, assess, protect and market commercially viable intellectual property developed at the University of Missouri. OTMIR evaluates new technologies, obtains patent protection where needed, identifies licensees and negotiates all intellectual property agreements.
Click here to learn more

Biodesign and Innovation Program

MU's Biodesign and Innovation Program improves health care through the invention and implementation of new medical technologies. The program facilitates interdisciplinary research, education and collaboration between faculty and fellows. The objective is to train knowledgeable, innovative professionals with the skills and capability to develop novel medical technologies, including the establishment of new start-up companies.
Click here to learn more

Missouri Innovation Center

The Missouri Innovation Center (MIC) is a nonprofit, 501(c)(3) that was established in 1984 with initial funding from the state of Missouri. MIC is designed to stimulate economic development through formation and incubation of technology ventures and to grow the technology industry cluster in mid-Missouri. MIC operates the Life Science Business Incubator at Monsanto Place and is a designated Innovation Center in the network of such centers recognized by the Missouri Department of Economic Development.
Click here to learn more

Tiger Institute for Health Innovation

A partnership between the Cerner Corporation and the University of Missouri, the Tiger Institute for Health Innovation develops and studies innovative medical informatics solutions that can facilitate storage and retrieval of patient-centered health care information. The institute includes a "Living Lab" that works closely with MU faculty to conceptualize, develop, and test new ways for improving health care delivery.
Click here to learn more

Centennial Investors: An "Angel Network"

Centennial Investors was founded in 2006 by the Columbia Chamber of Commerce to meet the early-stage needs of entrepreneurs at the University of Missouri. The major objective of Centennial Investors is to facilitate the process of bringing to market the innovative products and technologies developed at MU. Centennial Investors also raises capital through the Halo Fund and Catalyst Fund.
Click here to learn more

Enterprise Investment Program

The University of Missouri System Enterprise Investment Program (EIP) provides funds for start-up and early-stage companies if their goal is to commercialize intellectual property developed at the university. EIP is designed to facilitate the commercialization of intellectual property developed at the university in order to create jobs and to generate lasting economic benefits to the state of Missouri.
Click here to learn more

For more information about the Biomedical Innovators Group, please contact Debbie Taylor at taylord@health.missouri.edu or (573) 884-0042.

Click here to download information about the Biomedical Innovators Group.



Mizzou Advantage